StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) shareholders

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Ownership

Who owns Bioxytran's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 0 sales
Net bought $126.00K

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David PlattCEO, Director, 10% owner20,038,90317.47%Nov 18, 2025
Ola SoderquistCFO, 10% owner13,976,45612.19%Nov 18, 2025
Michael SheikhCCO, 10% owner8,214,7207.16%Nov 18, 2025
Dale H. ConawayDirector379,1770.33%Nov 18, 2025
Anders UtterDirector372,5800.32%Nov 18, 2025
Alan M. HobermanDirector210,0000.18%Nov 18, 2025
Radka MilanovaDirector203,6880.18%Nov 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Alan M. Hoberman
Director
Nov 18, 2025Buy+210,000$0.60$126.00K210,000
Radka Milanova
Director
Nov 14, 2025Award+38,588$0.35$13.51K203,688
Anders Utter
Director
Nov 14, 2025Award+38,588$0.35$13.51K372,580
Dale H. Conaway
Director
Nov 14, 2025Award+38,588$0.35$13.51K379,177
Alan M. Hoberman
Director
Nov 14, 2025Award+38,588$0.35$13.51K416,207
Radka Milanova
Director
Aug 12, 2025Award+10,417$0.49$5.10K165,100
Dale H. Conaway
Director
Aug 12, 2025Award+10,417$0.49$5.10K340,589
Alan M. Hoberman
Director
Aug 12, 2025Award+10,417$0.49$5.10K377,619
Dale H. Conaway
Director
Jan 6, 2025Award+97,535$0.32$31.21K330,172
Radka Milanova
Director
Jan 6, 2025Award+97,535$0.32$31.21K154,683
Alan M. Hoberman
Director
Jan 6, 2025Award+97,535$0.32$31.21K367,202
Anders Utter
Director
Jan 6, 2025Award+97,535$0.32$31.21K333,992
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other+10,069,396$0.55$5.54M13,976,456
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other+100,000$0.01$1.00K13,876,456
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other+500,000––500,000
Michael Sheikh
CCO, 10% owner
Oct 25, 2024Other+6,614,720$0.55$3.64M8,214,720
Alan M. Hoberman
Director
Oct 25, 2024Award+20,619$0.46$9.48K269,667
David Platt
CEO, Director, 10% owner
Oct 25, 2024Other+11,190,077$0.55$6.15M19,795,532
David Platt
CEO, Director, 10% owner
Oct 25, 2024Other−14,085,410$0.29$4.08M0
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other−100,000$0.01$1.00K14,004,671
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other+500,000––500,000
Ola Soderquist
CFO, 10% owner
Oct 25, 2024Other+10,197,611$0.55$5.61M14,104,671
Dale H. Conaway
Director
Oct 25, 2024Award+20,619$0.46$9.48K232,637
Radka Milanova
Director
Oct 25, 2024Award+20,619$0.46$9.48K57,148
Anders Utter
Director
Oct 25, 2024Award+20,619$0.46$9.48K236,457
David Platt
CEO, Director, 10% owner
Oct 24, 2024Other−14,085,410$0.29$4.08M0
David Platt
CEO, Director, 10% owner
Oct 24, 2024Other+11,433,448$0.55$6.29M20,038,903
Michael Sheikh
Chief Communications Officer
Oct 24, 2024Other+6,473,921$0.55$3.56M8,073,921
Dale H. Conaway
Director
Aug 19, 2024Other+1,060,089$0.17$180.22K0
Dale H. Conaway
Director
Aug 19, 2024Other+212,018$0.84$178.10K212,018
Michael Sheikh
Chief Communications Officer
Aug 19, 2024Other+1,600,000$0.02$32.00K1,600,000
Michael Sheikh
Chief Communications Officer
Aug 19, 2024Other−8,000,000––0
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other+82,260$0.01$82382,260
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other−411,300––0
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other+776,817$0.46$357.34K14,085,410
David Platt
CEO, Director, 10% owner
Aug 19, 2024Conversion+8,973,405$0.02$179.47K13,308,593
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other+4,335,188$0.81$3.51M4,335,188
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other−21,675,939$0.16$3.47M0
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other+8,605,455$0.01$86.05K8,605,455
David Platt
CEO, Director, 10% owner
Aug 19, 2024Other−43,027,274––0
Ola Soderquist
CFO, 10% owner
Aug 19, 2024Other−19,535,300––0
Ola Soderquist
CFO, 10% owner
Aug 19, 2024Other+3,907,060$0.05$195.35K3,907,060
Radka Milanova
Director
Aug 19, 2024Other+36,529$0.66$24.11K36,529
Radka Milanova
Director
Aug 19, 2024Other−182,645$0.13$23.74K0
Alan M. Hoberman
Director
Aug 19, 2024Other+226,678$0.80$181.34K226,678
Alan M. Hoberman
Director
Aug 19, 2024Other−1,133,389$0.16$181.34K0
Anders Utter
Director
Aug 19, 2024Other−1,079,189$0.17$183.46K0
Anders Utter
Director
Aug 19, 2024Other+215,838$0.83$179.15K215,838
Dale H. Conaway
Director
Aug 16, 2024Award+123,967$0.12$14.88K1,060,089
Radka Milanova
Director
Aug 16, 2024Award+82,645$0.12$9.92K182,645
Alan M. Hoberman
Director
Aug 16, 2024Award+123,967$0.12$14.88K1,133,389
Anders Utter
Director
Aug 16, 2024Award+123,967$0.12$14.88K1,079,189
David Platt
CEO, Director, 10% owner
Aug 15, 2024Buy+1,592,921$0.12$191.15K21,675,939
Dale H. Conaway
Director
Apr 19, 2024Award+70,423$0.14$9.86K936,122
Radka Milanova
Director
Apr 19, 2024Award+70,423$0.14$9.86K955,222
Alan M. Hoberman
Director
Apr 19, 2024Award+70,423$0.14$9.86K1,009,422
David Platt
CEO, Director, 10% owner
Mar 27, 2024Award+439,595$0.10$43.96K20,133,018
Anders Utter
Director
Mar 27, 2024Award+266,955$0.11$29.37K874,576
Alan M. Hoberman
Director
Mar 27, 2024Award+266,955$0.11$29.37K928,776
Dale H. Conaway
Director
Mar 27, 2024Award+266,955$0.11$29.37K855,476

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Sep 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
–
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bioxytran's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?